Combination therapy of lovastatin and AMPK activator improves mitochondrial and peroxisomal functions and clinical disease in EAE model.
This article is protected by copyright. All rights reserved.
PMID: 29331024 [PubMed - as supplied by publisher]
Source: Immunology - Category: Allergy & Immunology Authors: Singh I, Samuvel DJ, Choi S, Saxena N, Singh AK, Won J Tags: Immunology Source Type: research
More News: Allergy & Immunology | Autoimmune Disease | Cholesterol | Gastroschisis Repair | Lovastatin | Mitochondria | Mitochondrial Disease | Multiple Sclerosis | Statin Therapy | Study